Diabetes Mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For proposals 1 and 2, participants in the first group must be between 18 and 70 years of age; be diagnosed with periodontitis stages II to IV (moderate to severe), grade A to C; with at least two non-adjacent interproximal sites presenting a probing depth greater than or equal to five millimeters; a clinical attachment level greater than or equal to three millimeters and bleeding on probing in all four quadrants; as well as a minimum of fifteen natural teeth. Participants in the second group must present a diagnosis of uncontrolled type 2 diabetes mellitus, with glycated hemoglobin levels greater than or equal to 7%. Participants in the third group must smoke ten or more cigarettes per day for at least three years. For proposal 3, participants must present maxillary and/or mandibular molars with bilateral grade II furcation involvement, located on the buccal, mesial, or distal surfaces of the maxilla or mandible; or the presence of an intrabony defect; a probing depth greater than or equal to five millimeters and a horizontal probing depth greater than or equal to three millimeters (for furcation lesions) after non-surgical periodontal therapy; intraoral periapical radiographs showing radiolucency between the roots for grade II furcation defects and at least three millimeters of evident bone loss on periapical radiographs for intrabony defects; with no endodontic involvement or with satisfactory endodontic treatment
Exclusion criteria
Exclusion criteria: Medical disorders that required antibiotic prophylaxis or that could influence the response to treatment; having received periodontal treatment in the last 6 months; having used medications that affect periodontal tissues in the last 6 months; smokers or ex-smokers for less than 12 months; pregnancy; extensive prosthetic rehabilitation; undergoing orthodontic treatment; carriers of blood diseases; alcoholism and use of illicit drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvements are expected in periodontal clinical parameters assessed using a millimeter periodontal probe. Data collected before the intervention and after 45 and 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of interproximal bone loss by periapical radiographs (baseline and 90 days);Immunological analyses will be performed before the intervention and after 45 and 90 days by ELISA to assess the protein levels of IL-1, TNF, and TGF-ß.;Assessment of periodontopathogen levels by RT-qPCR (baseline, 45 and 90 days) | — |
Countries
Brazil
Contacts
Faculdade de Odontologia da Universidade Federal de Uberlândia;Faculdade de Odontologia da Universidade Federal de Uberlândia